Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth
Abstract Honokiol (HNK) is a small molecule with potent anti-inflammatory and anti-tumorigenic properties; yet the molecular targets of HNK are not well studied. Hyperactivation of the receptor tyrosine kinase c-Met and overexpression of the cytoprotective enzyme heme oxygenase-1 (HO-1) play a criti...
Guardado en:
Autores principales: | Murugabaskar Balan, Samik Chakraborty, Evelyn Flynn, David Zurakowski, Soumitro Pal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/637987d188484da5882938b1a74f7fcd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Old and New Calcineurin Inhibitors in Lupus Nephritis
por: Claudio Ponticelli, et al.
Publicado: (2021) -
Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation
por: Anna Bogacz, et al.
Publicado: (2021) -
Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
por: Roesel M, et al.
Publicado: (2011) -
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
por: Michael Sticherling
Publicado: (2011) -
Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
por: Wada A, et al.
Publicado: (2016)